|
No of patients
|
Sex
|
Age (years)
|
Localization
|
Tumor Characteristic
|
No of treatments
|
Duration of individual months follow up
|
Response
|
|---|
|
1
|
F
|
62
|
Nose
|
G1
|
1
|
22
|
CR
|
|
2
|
M
|
78
|
Scalp
|
G1
|
1
|
36
|
PR
|
|
3
|
M
|
75
|
Nose
|
G1
|
1
|
31
|
PR
|
|
4
|
M
|
72
|
Ear
|
G2
|
1
|
5
|
CR
|
|
5
|
M
|
64
|
Back
|
G3
|
1
|
36
|
PR
|
|
6
|
M
|
69
|
Forehead
|
G1
|
1
|
41
|
PR
|
|
7
|
M
|
53
|
Foot
|
G3
|
2
|
48
|
CR
|
|
8
|
M
|
54
|
Foot
|
G2
|
3
|
40
|
PD
|
|
9
|
M
|
73
|
Foot
|
G2
|
1
|
24
|
PR
|
|
10
|
F
|
51
|
Nose
|
G1
|
1
|
26
|
CR
|
|
11
|
M
|
64
|
Lip
|
G2
|
2
|
37
|
PR
|
|
12
|
M
|
87
|
Scalp
|
G2
|
2
|
40
|
SD
|
|
13
|
M
|
65
|
Foot
|
G2
|
1
|
26
|
CR
|
|
14
|
F
|
52
|
Cheek
|
G1
|
1
|
34
|
PR
|
|
15
|
F
|
84
|
Scalp
|
G1
|
1
|
26
|
SD
|
|
16
|
M
|
80
|
Ear
|
G2
|
1
|
28
|
PD
|
|
17
|
F
|
74
|
Cheek
|
G1
|
2
|
36
|
PR
|
|
18
|
M
|
88
|
Scalp
|
G2
|
1
|
31
|
PR
|
|
19
|
F
|
75
|
Scalp
|
G1
|
2
|
38
|
SD
|
|
20
|
M
|
78
|
Scalp
|
G1
|
2
|
35
|
PR
|
|
21
|
F
|
82
|
Nape
|
G1
|
1
|
34
|
PR
|
|
22
|
M
|
51
|
Leg
|
G1
|
1
|
32
|
PR
|
- Overall response evaluated at 4 weeks is shown
